Form 8-K - Current report:
SEC Accession No. 0001104659-22-003797
Filing Date
2022-01-13
Accepted
2022-01-13 08:00:44
Documents
36
Period of Report
2022-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm222647d1_8k.htm   iXBRL 8-K 30778
2 EXHIBIT 99.1 tm222647d1_ex99-1.htm EX-99.1 28150
3 GRAPHIC tm222647d1_ex99-1img001.jpg GRAPHIC 119924
4 GRAPHIC tm222647d1_ex99-1img002.jpg GRAPHIC 229524
5 GRAPHIC tm222647d1_ex99-1img003.jpg GRAPHIC 139713
6 GRAPHIC tm222647d1_ex99-1img004.jpg GRAPHIC 113063
7 GRAPHIC tm222647d1_ex99-1img005.jpg GRAPHIC 93623
8 GRAPHIC tm222647d1_ex99-1img006.jpg GRAPHIC 191905
9 GRAPHIC tm222647d1_ex99-1img007.jpg GRAPHIC 182267
10 GRAPHIC tm222647d1_ex99-1img008.jpg GRAPHIC 160307
11 GRAPHIC tm222647d1_ex99-1img009.jpg GRAPHIC 97894
12 GRAPHIC tm222647d1_ex99-1img010.jpg GRAPHIC 192981
13 GRAPHIC tm222647d1_ex99-1img011.jpg GRAPHIC 129448
14 GRAPHIC tm222647d1_ex99-1img012.jpg GRAPHIC 101335
15 GRAPHIC tm222647d1_ex99-1img013.jpg GRAPHIC 223777
16 GRAPHIC tm222647d1_ex99-1img014.jpg GRAPHIC 200898
17 GRAPHIC tm222647d1_ex99-1img015.jpg GRAPHIC 136627
18 GRAPHIC tm222647d1_ex99-1img016.jpg GRAPHIC 143692
19 GRAPHIC tm222647d1_ex99-1img017.jpg GRAPHIC 146695
20 GRAPHIC tm222647d1_ex99-1img018.jpg GRAPHIC 178188
21 GRAPHIC tm222647d1_ex99-1img019.jpg GRAPHIC 144935
22 GRAPHIC tm222647d1_ex99-1img020.jpg GRAPHIC 99656
23 GRAPHIC tm222647d1_ex99-1img021.jpg GRAPHIC 135258
24 GRAPHIC tm222647d1_ex99-1img022.jpg GRAPHIC 139504
25 GRAPHIC tm222647d1_ex99-1img023.jpg GRAPHIC 118257
  Complete submission text file 0001104659-22-003797.txt   4955555

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA apre-20220113.xsd EX-101.SCH 3024
27 XBRL TAXONOMY EXTENSION LABEL LINKBASE apre-20220113_lab.xml EX-101.LAB 34476
28 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apre-20220113_pre.xml EX-101.PRE 22589
30 EXTRACTED XBRL INSTANCE DOCUMENT tm222647d1_8k_htm.xml XML 3645
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 22527901
SIC: 2834 Pharmaceutical Preparations